Aptahem AB (XSAT:APTA) Interest Expense : kr-1.22 Mil (TTM As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Aptahem AB Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Aptahem AB's interest expense for the three months ended in Mar. 2024 was kr -0.21 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was kr-1.22 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Aptahem AB's Operating Income for the three months ended in Mar. 2024 was kr -2.52 Mil. Aptahem AB's Interest Expense for the three months ended in Mar. 2024 was kr -0.21 Mil. Aptahem AB did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Aptahem AB Interest Expense Historical Data

The historical data trend for Aptahem AB's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptahem AB Interest Expense Chart

Aptahem AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-1.01

Aptahem AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-	-	-	-1.01	-0.21

Aptahem AB Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-1.22 Mil.

Aptahem AB (XSAT:APTA) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Aptahem AB's Interest Expense for the three months ended in Mar. 2024 was kr-0.21 Mil. Its Operating Income for the three months ended in Mar. 2024 was kr-2.52 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was kr0.00 Mil.

Aptahem AB's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Aptahem AB did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Aptahem AB (XSAT:APTA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptahem AB (XSAT:APTA) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Norra Vallgatan 58, Malmo, SWE, 211 22

Website

http://www.aptahem.com

Aptahem AB develops aptamer-based drugs for the treatment of acute life-threatening conditions where coagulation and inflammation interact in the disease process. The company's main candidate Apta-1 is developed as an emergency medicine intended to prevent the occurrence of life-threatening organ and tissue damage in patients suffering from sepsis.

Aptahem AB (XSAT:APTA) Headlines

No Headlines